Danaher Ventures

Overview

Danaher Ventures is the corporate venture capital arm of Danaher Corporation, established in 2017 to invest in early-stage, breakthrough technologies across biotechnology, diagnostics, life sciences, and data sciences. Operating at the intersection of strategy, science, and technology, Danaher Ventures leverages Danaher's resources, including the Danaher Business System, to drive transformation at scale across life sciences and diagnostics. The mission is to tackle critical challenges in healthcare and biology by making life-saving therapies and diagnostics more accessible globally. The investment strategy of Danaher Ventures focuses on three key areas: biotechnology, diagnostics, and life sciences. In biotechnology, the aim is to access cutting-edge platforms to advance groundbreaking medicines. In diagnostics, the goal is to deliver precision diagnostics at the right time and place. In life sciences, the focus is on accelerating the discovery, development, and delivery of therapeutic solutions. By investing in and partnering with leading entrepreneurs and investors, Danaher Ventures seeks to launch, build, and scale transformative companies that address critical healthcare challenges. Danaher Ventures operates with a deep sense of responsibility to enable science and technology for the betterment of humanity. The team comprises scientists, entrepreneurs, engineers, and commercial leaders with a passion for improving human health. By combining Danaher's innovative mindset, world-class talent, industry-leading expertise, and access to capital, Danaher Ventures aims to drive impactful innovation in the healthcare sector. In January 2025, Danaher Ventures formed an investment partnership with Innovaccer Inc., a leading healthcare artificial intelligence company. This partnership aims to improve patient outcomes and experience through novel digital and diagnostic solutions, aligning with Danaher's mission to accelerate the transition to precision medicine with AI-enabled diagnostics. Innovaccer's suite of software solutions is designed to create unified patient records, identify gaps in care, and facilitate value-based care, thereby enhancing the adoption of precision diagnostics by clinicians and population health teams. Danaher Ventures continues to seek investment opportunities that align with its mission to improve human health by addressing critical challenges in healthcare and biology. Through strategic investments and partnerships, Danaher Ventures aims to drive innovation and deliver transformative solutions in the life sciences and diagnostics sectors.

Investment Focus

• Innovative technologies in biotechnology, diagnostics, life sciences, and data sciences
• Early-stage companies with transformative potential
• Entrepreneurial teams with a proven track record of translating innovation into impactful products

Portfolio Companies